2008 - Society for Cardiothoracic Surgery
2008 - Society for Cardiothoracic Surgery
2008 - Society for Cardiothoracic Surgery
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Society</strong> <strong>for</strong> <strong>Cardiothoracic</strong> <strong>Surgery</strong> • Edinburgh<br />
Monday 10th March Session 1<br />
008:30 – 08:40 Ochil Abstract No. 4<br />
The Novel Peroxynitrite Decomp4osition Catalyst FP15 Improves<br />
Cardiac & Pulmonary Function after Cardiopulmonary Bypass<br />
Authors: G Szabó; T Radovits; C Beller; M Karck<br />
Author’s Institution: University of Heidelberg, Heidelberg, Germany<br />
Objectives: Peroxynitrite is highly active free radical species which plays a central role in<br />
ischaemia/reperfusion injury. We investigated the effects of FP15, a novel peroxynitrite<br />
decomposition catalyst on ischaemia/reperfusion injury in an experimental model of<br />
cardioplegic arrest and extracorporeal circulation.<br />
Methods: Twelve anesthetized dogs underwent hypothermic cardiopulmonary bypass.<br />
After 60 minutes of hypothermic cardiac arrest, reperfusion was started after application<br />
of either saline vehicle (control, n = 6), or FP15 (0.1mg/kg n=6). Left ventricular endsystolic<br />
pressure volume relationship (Ees) was measured by a combined pressurevolume-conductance<br />
catheter at baseline and after 60 minutes of reperfusion. Left<br />
anterior descending coronary blood flow (CBF) and pulmonary blood flow (PBF),<br />
endothelium-dependent vasodilatation to acetylcholine (ACH) and endotheliumindependent<br />
vasodilatation to sodium nitroprusside (SNP) and alveolo-arterial O 2<br />
gradient were determined.<br />
Results: The administration of FP15 led to a significantly better recovery (given as<br />
percent of baseline) of Ees 88±7 % vs. 46±6 %, p